Akshyaya C. Rath
Ahmedabad, GJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia.
Journal: Vaccines
Published: July 02, 2025
Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 29, 2024
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.
Journal: Bioorganic & medicinal chemistry
Published: December 07, 2020
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 21, 2017
Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.
Journal: Pharmacology research & perspectives
Published: January 28, 2015
Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.
Journal: Indian journal of pharmacology
Published: September 26, 2014
Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
Journal: Indian journal of pharmacology
Published: January 09, 2014
Synthesis and structure-activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: application of weakly basic sulfoximine group as novel S4 binding element.
Journal: European journal of medicinal chemistry
Published: May 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026